Get started
Author

Tatyana Benisheva

Observed names: Benisheva, Tatyana, T Benisheva, T. Benisheva
ORCID: 0000-0001-7295-2586
Observed ORCID: 0000-0001-7295-2586
OpenAlex ID: A5079550257
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel
2021 · Karen M. Facey, Jaime Espin, et al. · PharmacoEconomics · 54
POSC209 Cost of Treatment with Biosimilars - Case with Rituximab in Oncohematology
2022 · E Boncheva, D Cherneva, et al. · Value in Health · 2
PRO74 Is IT Possible to Accelerate the Access of Patients with RARE Diseases to New Therapy – the Case with IPF Medicines
2020 · E. Boncheva, T. Benisheva, et al. · Value in Health · 2
PDF
Safety profiles of biosimilars vs. their EU reference products: INNs (adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, etanercept)
2025 · Valentin Kopanarov, Tatyana Benisheva, et al. · Biotechnology & Biotechnological Equipment · 1
Attitude of medical doctors to adverse drug reactions reporting in Bulgaria
2024 · Dobriana Sidjimova, Tatyana Benisheva, et al. · Pharmacia · 1
Conducting clinical trials in five Eastern European countries (EU-EECs) with a focus on Bulgaria
2023 · Tatyana Benisheva, Dimitar Milkov, et al. · Biotechnology & Biotechnological Equipment · 1
PDF
BREXIT consequences - relocation of the European Medicines Agency
2019 · Petya Trendafilova, Tatyana Benisheva, et al. · Scripta Scientifica Pharmaceutica · 1
PDF
Php320 - Analysis of Hta Process on the Basis of Pharmacoeconomic Guidelines in Central Eastern European Countries
2018 · D. Sidzhimova, T. Benisheva, et al. · Value in Health · 1
Pcn379 Hta Assessments of Metastatic Urothelial Carcinoma Treatment in Eu Countries
2019 · T. Benisheva, B. Borissov, et al. · Value in Health
PDF
The Use of Mcda In HTA Decision Making In Bulgaria
2017 · DAzzz Sidjimova, A Stoimenova, et al. · Value in Health
PDF
Investigating Comparator Requirements For Drug Selection For Cost-Effectiveness
2017 · T Benisheva, D Cherneva, et al. · Value in Health
Comparative Analysis of The Development of The Bulgarian and The Romanian HTA System
2017 · P Trendafilova, T Benisheva, et al. · Value in Health
Comparative Analysis of The Guidelines for Conducting Hta in Poland and Bulgaria
2016 · T Benisheva, PD Trendafilova, et al. · Value in Health
Analysis of Medicinal Products’ Expenditure Reimbursed by the National Health Insurance Fund in Bulgaria for Outpatient Care
2016 · Petya Trendafilova, Tatyana Benisheva, et al. · Open Journal of Social Sciences
PDF
Comparative analysis of the Bulgarian pharmaceutical legislation regarding clinical trials of medicinal products since 1995-2009.
2010 · Tatyana Benisheva, Р. Д. Васильева, et al. · Zdravna Politika i Menidzhm'nt / Health Policy and Management
Works count: 16
Citation count: 63
H-index: 2
I10-index: 1
Year
Topic
Type